{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T19:50:32Z","timestamp":1787946632722,"version":"build-2784847793"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T00:00:00Z","timestamp":1576800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T00:00:00Z","timestamp":1576800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100001245","name":"Jeffrey Modell Foundation","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100001245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012536","name":"Leeds Hospital Charitable Foundation","doi-asserted-by":"publisher","award":["9\/R21\/14-07"],"award-info":[{"award-number":["9\/R21\/14-07"]}],"id":[{"id":"10.13039\/100012536","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018955","name":"NIHR Leeds Biomedical Research Centre.","doi-asserted-by":"crossref","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100018955","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2020,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Inducible T cell co-stimulator (ICOS) deficiency has been categorized as a combined immunodeficiency often complicated by enteropathies, autoimmunity, lymphoproliferation, and malignancy. We report seven new patients and four novel<jats:italic>ICOS<\/jats:italic>mutations resulting in a common variable immunodeficiency (CVID)\u2013like phenotype and show that dysregulated IL-12 release, reduced cytotoxic T lymphocyte\u2013associated protein 4 (CTLA4) expression, and skewing towards a Th1-dominant phenotype are all associated with inflammatory complications in this condition.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A combination of whole exome and Sanger sequencing was used to identify novel mutations. Standard clinical and immunological evaluation was performed. FACS and ELISA-based assays were used to study cytokine responses and ICOS\/ICOSL\/CTLA4 expression following stimulation of whole blood and PBMCs with multiple TLR ligands, anti-CD3, and PHA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Four novel ICOS mutations included homozygous c.323_332del, homozygous c.451C&gt;G, and compound heterozygous c.58+1G&gt;A\/c.356T&gt;C. The predominant clinical phenotype was that of antibody deficiency associated with inflammatory complications in 4\/7 patients. Six out of seven patients were treated with immunoglobulin replacement and one patient died from salmonella sepsis. All patients who were tested showed reduced IL-10 and IL-17 cytokine responses, normal IL-1\u03b2, IL6, and TNF release following LPS stimulation and highly elevated IL-12 production in response to combined LPS\/IFN\u03b3 stimulation. This was associated with skewing of CD4<jats:sup>+<\/jats:sup>T cells towards Th1 phenotype and increased expression of ICOSL on monocytes. Lastly, reduced CTLA4 expression was found in 2 patients. One patient treated with ustekinumab for pancytopenia due to granulomatous bone marrow infiltration failed to respond to this targeted therapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>ICOS deficiency is associated with defective T cell activation, with simultaneously enhanced stimulation of monocytes. The latter is likely to result from a lack of ICOS\/ICOSL interaction which might be necessary to provide negative feedback which limits monocytes activation.<\/jats:p><\/jats:sec>","DOI":"10.1007\/s10875-019-00735-z","type":"journal-article","created":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T07:24:29Z","timestamp":1576826669000},"page":"277-288","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Expanding Clinical Phenotype and Novel Insights into the Pathogenesis of ICOS Deficiency"],"prefix":"10.1007","volume":"40","author":[{"given":"Hassan","family":"Abolhassani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasser M.","family":"El-Sherbiny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gururaj","family":"Arumugakani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clive","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan","family":"Lawless","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Buckland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzieh","family":"Heydarzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asghar","family":"Aghamohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Hambleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennart","family":"Hammarstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siobhan O","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Doffinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7910-0554","authenticated-orcid":false,"given":"Sinisa","family":"Savic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,20]]},"reference":[{"issue":"7","key":"735_CR1","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nri1131","volume":"3","author":"CE Rudd","year":"2003","unstructured":"Rudd CE, Schneider H. Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling. Nat Rev Immunol. 2003;3(7):544\u201356.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"735_CR2","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/nri727","volume":"2","author":"AH Sharpe","year":"2002","unstructured":"Sharpe AH, Freeman GJ. The B7-CD28 superfamily. Nat Rev Immunol. 2002;2(2):116\u201326.","journal-title":"Nat Rev Immunol"},{"issue":"6716","key":"735_CR3","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/16717","volume":"397","author":"A Hutloff","year":"1999","unstructured":"Hutloff A, Dittrich AM, Beier KC, Eljaschewitsch B, Kraft R, Anagnostopoulos I, et al. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature. 1999;397(6716):263\u20136.","journal-title":"Nature."},{"issue":"6763","key":"735_CR4","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/45582","volume":"402","author":"SK Yoshinaga","year":"1999","unstructured":"Yoshinaga SK, Whoriskey JS, Khare SD, Sarmiento U, Guo J, Horan T, et al. T-cell co-stimulation through B7RP-1 and ICOS. Nature. 1999;402(6763):827\u201332.","journal-title":"Nature."},{"issue":"9","key":"735_CR5","doi-asserted-by":"publisher","first-page":"5035","DOI":"10.4049\/jimmunol.165.9.5035","volume":"165","author":"AJ McAdam","year":"2000","unstructured":"McAdam AJ, Chang TT, Lumelsky AE, Greenfield EA, Boussiotis VA, Duke-Cohan JS, et al. Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4+ T cells. J Immunol. 2000;165(9):5035\u201340.","journal-title":"J Immunol"},{"issue":"3","key":"735_CR6","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1093\/intimm\/dxh206","volume":"17","author":"M Watanabe","year":"2005","unstructured":"Watanabe M, Hara Y, Tanabe K, Toma H, Abe R. A distinct role for ICOS-mediated co-stimulatory signaling in CD4+ and CD8+ T cell subsets. Int Immunol. 2005;17(3):269\u201378.","journal-title":"Int Immunol"},{"issue":"4","key":"735_CR7","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S1074-7613(00)80117-X","volume":"11","author":"MM Swallow","year":"1999","unstructured":"Swallow MM, Wallin JJ, Sha WC. B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNFalpha. Immunity. 1999;11(4):423\u201332.","journal-title":"Immunity."},{"issue":"9","key":"735_CR8","doi-asserted-by":"publisher","first-page":"6198","DOI":"10.1073\/pnas.092576699","volume":"99","author":"S Khayyamian","year":"2002","unstructured":"Khayyamian S, Hutloff A, Buchner K, Grafe M, Henn V, Kroczek RA, et al. ICOS-ligand, expressed on human endothelial cells, costimulates Th1 and Th2 cytokine secretion by memory CD4+ T cells. Proc Natl Acad Sci U S A. 2002;99(9):6198\u2013203.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"735_CR9","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1097\/01.ASN.0000017901.77985F","volume":"13","author":"P Wahl","year":"2002","unstructured":"Wahl P, Schoop R, Bilic G, Neuweiler J, Le Hir M, Yoshinaga SK, et al. Renal tubular epithelial expression of the costimulatory molecule B7RP-1 (inducible costimulator ligand). J Am Soc Nephrol. 2002;13(6):1517\u201326.","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"735_CR10","doi-asserted-by":"publisher","first-page":"4689","DOI":"10.4049\/jimmunol.164.9.4689","volume":"164","author":"A Aicher","year":"2000","unstructured":"Aicher A, Hayden-Ledbetter M, Brady WA, Pezzutto A, Richter G, Magaletti D, et al. Characterization of human inducible costimulator ligand expression and function. J Immunol. 2000;164(9):4689\u201396.","journal-title":"J Immunol"},{"issue":"8","key":"735_CR11","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1007\/s10875-015-0201-1","volume":"35","author":"C Picard","year":"2015","unstructured":"Picard C, Al-Herz W, Bousfiha A, Casanova JL, Chatila T, Conley ME, et al. Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for primary immunodeficiency 2015. J Clin Immunol. 2015;35(8):696\u2013726.","journal-title":"J Clin Immunol"},{"issue":"3","key":"735_CR12","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/ni902","volume":"4","author":"B Grimbacher","year":"2003","unstructured":"Grimbacher B, Hutloff A, Schlesier M, Glocker E, Warnatz K, Drager R, et al. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol. 2003;4(3):261\u20138.","journal-title":"Nat Immunol"},{"issue":"3","key":"735_CR13","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.clim.2004.07.002","volume":"113","author":"U Salzer","year":"2004","unstructured":"Salzer U, Maul-Pavicic A, Cunningham-Rundles C, Urschel S, Belohradsky BH, Litzman J, et al. ICOS deficiency in patients with common variable immunodeficiency. Clin Immunol. 2004;113(3):234\u201340.","journal-title":"Clin Immunol"},{"issue":"7","key":"735_CR14","doi-asserted-by":"publisher","first-page":"4927","DOI":"10.4049\/jimmunol.177.7.4927","volume":"177","author":"L Bossaller","year":"2006","unstructured":"Bossaller L, Burger J, Draeger R, Grimbacher B, Knoth R, Plebani A, et al. ICOS deficiency is associated with a severe reduction of CXCR5+CD4 germinal center Th cells. J Immunol. 2006;177(7):4927\u201332.","journal-title":"J Immunol"},{"issue":"9","key":"735_CR15","doi-asserted-by":"publisher","first-page":"5515","DOI":"10.4049\/jimmunol.0803256","volume":"182","author":"N Takahashi","year":"2009","unstructured":"Takahashi N, Matsumoto K, Saito H, Nanki T, Miyasaka N, Kobata T, et al. Impaired CD4 and CD8 effector function and decreased memory T cell populations in ICOS-deficient patients. J Immunol. 2009;182(9):5515\u201327.","journal-title":"J Immunol"},{"issue":"3","key":"735_CR16","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nm.3806","volume":"21","author":"RC Coll","year":"2015","unstructured":"Coll RC, Robertson AA, Chae JJ, Higgins SC, Munoz-Planillo R, Inserra MC, et al. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat Med. 2015;21(3):248\u201355.","journal-title":"Nat Med"},{"issue":"3","key":"735_CR17","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.jaci.2014.12.1940","volume":"136","author":"J Chou","year":"2015","unstructured":"Chou J, Massaad MJ, Cangemi B, Bainter W, Platt C, Badran YR, et al. A novel mutation in ICOS presenting as hypogammaglobulinemia with susceptibility to opportunistic pathogens. J Allergy Clin Immunol. 2015;136(3):794\u20137 e1.","journal-title":"J Allergy Clin Immunol"},{"key":"735_CR18","doi-asserted-by":"publisher","first-page":"964","DOI":"10.3389\/fimmu.2017.00964","volume":"8","author":"J Schepp","year":"2017","unstructured":"Schepp J, Chou J, Skrabl-Baumgartner A, Arkwright PD, Engelhardt KR, Hambleton S, et al. 14 years after discovery: clinical follow-up on 15 patients with inducible co-stimulator deficiency. Front Immunol. 2017;8:964.","journal-title":"Front Immunol"},{"issue":"1","key":"735_CR19","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s41436-018-0012-x","volume":"21","author":"H Abolhassani","year":"2019","unstructured":"Abolhassani H, Aghamohammadi A, Fang M, Rezaei N, Jiang C, Liu X, et al. Clinical implications of systematic phenotyping and exome sequencing in patients with primary antibody deficiency. Genet Med. 2019;21(1):243\u201351.","journal-title":"Genet Med"},{"issue":"3","key":"735_CR20","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1006\/clim.1999.4799","volume":"93","author":"ME Conley","year":"1999","unstructured":"Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol. 1999;93(3):190\u20137.","journal-title":"Clin Immunol"},{"issue":"5 Suppl 1","key":"735_CR21","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/S1081-1206(10)61142-8","volume":"94","author":"FA Bonilla","year":"2005","unstructured":"Bonilla FA, Bernstein IL, Khan DA, Ballas ZK, Chinen J, Frank MM, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. Ann Allergy Asthma Immunol. 2005;94(5 Suppl 1):S1\u201363.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"735_CR22","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/j.jaci.2014.04.042","volume":"134","author":"H Abolhassani","year":"2014","unstructured":"Abolhassani H, Wang N, Aghamohammadi A, Rezaei N, Lee YN, Frugoni F, et al. A hypomorphic recombination-activating gene 1 (RAG1) mutation resulting in a phenotype resembling common variable immunodeficiency. J Allergy Clin Immunol. 2014;134(6):1375\u201380.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"735_CR23","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/sji.12040","volume":"77","author":"N Arandi","year":"2013","unstructured":"Arandi N, Mirshafiey A, Abolhassani H, Jeddi-Tehrani M, Edalat R, Sadeghi B, et al. Frequency and expression of inhibitory markers of CD4(+) CD25(+) FOXP3(+) regulatory T cells in patients with common variable immunodeficiency. Scand J Immunol. 2013;77(5):405\u201312.","journal-title":"Scand J Immunol"},{"issue":"3","key":"735_CR24","first-page":"160","volume":"22","author":"M Oraei","year":"2012","unstructured":"Oraei M, Aghamohammadi A, Rezaei N, Bidad K, Gheflati Z, Amirkhani A, et al. Naive CD4+ T cells and recent thymic emigrants in common variable immunodeficiency. J Investig Allergol Clin Immunol. 2012;22(3):160\u20137.","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"1\u20132","key":"735_CR25","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jim.2013.05.008","volume":"394","author":"A Salek Farrokhi","year":"2013","unstructured":"Salek Farrokhi A, Aghamohammadi A, Pourhamdi S, Mohammadinejad P, Abolhassani H, Moazzeni SM. Evaluation of class switch recombination in B lymphocytes of patients with common variable immunodeficiency. J Immunol Methods. 2013;394(1\u20132):94\u20139.","journal-title":"J Immunol Methods"},{"issue":"Suppl 1","key":"735_CR26","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s10875-016-0260-y","volume":"36","author":"M Fang","year":"2016","unstructured":"Fang M, Abolhassani H, Lim CK, Zhang J, Hammarstrom L. Next generation sequencing data analysis in primary immunodeficiency disorders - future directions. J Clin Immunol. 2016;36(Suppl 1):68\u201375.","journal-title":"J Clin Immunol"},{"issue":"5","key":"735_CR27","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405\u201324.","journal-title":"Genet Med."},{"issue":"2","key":"735_CR28","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nmeth.3739","volume":"13","author":"Y Itan","year":"2016","unstructured":"Itan Y, Shang L, Boisson B, Ciancanelli MJ, Markle JG, Martinez-Barricarte R, et al. The mutation significance cutoff: gene-level thresholds for variant predictions. Nat Methods. 2016;13(2):109\u201310.","journal-title":"Nat Methods"},{"issue":"3","key":"735_CR29","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/ng.2892","volume":"46","author":"M Kircher","year":"2014","unstructured":"Kircher M, Witten DM, Jain P, O\u2019Roak BJ, Cooper GM, Shendure J. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet. 2014;46(3):310\u20135.","journal-title":"Nat Genet"},{"issue":"8","key":"735_CR30","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1084\/jem.20011607","volume":"195","author":"S Wang","year":"2002","unstructured":"Wang S, Zhu G, Tamada K, Chen L, Bajorath J. Ligand binding sites of inducible costimulator and high avidity mutants with improved function. J Exp Med. 2002;195(8):1033\u201341.","journal-title":"J Exp Med"},{"issue":"8","key":"735_CR31","doi-asserted-by":"publisher","first-page":"5222","DOI":"10.4049\/jimmunol.180.8.5222","volume":"180","author":"M Watanabe","year":"2008","unstructured":"Watanabe M, Takagi Y, Kotani M, Hara Y, Inamine A, Hayashi K, et al. Down-regulation of ICOS ligand by interaction with ICOS functions as a regulatory mechanism for immune responses. J Immunol. 2008;180(8):5222\u201334.","journal-title":"J Immunol"},{"issue":"2","key":"735_CR32","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.jaci.2017.04.041","volume":"141","author":"S Unger","year":"2018","unstructured":"Unger S, Seidl M, van Schouwenburg P, Rakhmanov M, Bulashevska A, Frede N, et al. The TH1 phenotype of follicular helper T cells indicates an IFN-gamma-associated immune dysregulation in patients with CD21low common variable immunodeficiency. J Allergy Clin Immunol. 2018;141(2):730\u201340.","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"735_CR33","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/nm.3746","volume":"20","author":"D Schubert","year":"2014","unstructured":"Schubert D, Bode C, Kenefeck R, Hou TZ, Wing JB, Kennedy A, et al. Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations. Nat Med. 2014;20(12):1410\u20136.","journal-title":"Nat Med"},{"issue":"6204","key":"735_CR34","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1126\/science.1255904","volume":"345","author":"HS Kuehn","year":"2014","unstructured":"Kuehn HS, Ouyang W, Lo B, Deenick EK, Niemela JE, Avery DT, et al. Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4. Science. 2014;345(6204):1623\u20137.","journal-title":"Science."},{"issue":"6","key":"735_CR35","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1016\/j.jaci.2018.02.055","volume":"142","author":"C Schwab","year":"2018","unstructured":"Schwab C, Gabrysch A, Olbrich P, Patino V, Warnatz K, Wolff D, et al. Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects. J Allergy Clin Immunol. 2018;142(6):1932\u201346.","journal-title":"J Allergy Clin Immunol"},{"key":"735_CR36","doi-asserted-by":"crossref","unstructured":"Kiykim A, Ogulur I, Dursun E, Charbonnier LM, Nain E, Cekic S, et al. Abatacept as a Long-Term Targeted Therapy for LRBA Deficiency. J Allergy Clin Immunol Pract. 2019.","DOI":"10.1016\/j.jaip.2019.06.011"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-019-00735-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-019-00735-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-019-00735-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,9]],"date-time":"2022-10-09T02:51:34Z","timestamp":1665283894000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-019-00735-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,20]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["735"],"URL":"https:\/\/doi.org\/10.1007\/s10875-019-00735-z","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,20]]},"assertion":[{"value":"5 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}